Page last updated: 2024-10-23

azathioprine and HTLV-I Infections

azathioprine has been researched along with HTLV-I Infections in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

HTLV-I Infections: Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frederick, WR1
Callender, CO1
Saxinger, CW1
Flores, JC1
Alexander, SS1
Barnes, SE1
Flagg, R1
Walters, CS1
Dunston, GM1
Greaves, WL1

Other Studies

1 other study available for azathioprine and HTLV-I Infections

ArticleYear
Serologic and immunologic correlates of retroviral infection in transplant recipients.
    Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Azathioprine; Cyclosporins; Drug Therapy, Combination; Fe

1989